Related Experiment Video
Updated: Aug 9, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axl
Bo-Kyung Son1, Koichi Kozaki, Katsuya Iijima
1Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
Insights
Statins prevent vascular calcification by inhibiting apoptosis in human aortic smooth muscle cells. This effect is mediated by restoring the Gas6-Axl pathway, crucial for cell survival.
Area of Science:
- Cardiovascular Biology
- Cellular and Molecular Medicine
- Pharmacology
Background:
- Vascular calcification is a key factor in cardiovascular disease development.
- Statins (HMG CoA reductase inhibitors) show potential in inhibiting vascular calcification, but mechanisms remain unclear.
- Apoptosis is increasingly recognized as a regulator of vascular smooth muscle cell (VSMC) calcification.
Purpose of the Study:
- To investigate the effect of statins on VSMC calcification.
- To elucidate the role of apoptosis and the Gas6-Axl pathway in statin-mediated inhibition of vascular calcification.
Main Methods:
- Used human aortic smooth muscle cells (HASMC) treated with inorganic phosphate (Pi) and statins.
- Assessed calcification, apoptosis, sodium-dependent phosphate cotransporter (NPC) activity, and Gas6/Axl pathway expression.
- Utilized small interfering RNA (siRNA) to suppress Gas6 and Axl function.
Main Results:
- Statins significantly inhibited Pi-induced HASMC calcification in a dose-dependent manner.
- Statin's inhibitory effect was linked to preventing Pi-induced apoptosis, not altering NPC activity.
- Statins restored Gas6 expression, which was downregulated by Pi, via mRNA stabilization.
- Suppression of Gas6 or Axl abolished the protective effects of statins.
Conclusions:
- Statins protect HASMC from Pi-induced calcification by inhibiting apoptosis.
- The mechanism involves the restoration of the Gas6-Axl survival pathway.
- Targeting the Gas6-Axl pathway may offer therapeutic strategies for vascular calcification.
Abstract:
Vascular calcification is clinically important in the development of cardiovascular disease. It is reported that hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors (statins) inhibited vascular calcification in several clinical trials. However, the mechanism is poorly understood. Recently, it has been suggested that apoptosis is one of the important processes regulating vascular smooth muscle cell (VSMC) calcification. In this study, we investigated the effect of statins on VSMC calcification by testing their effect on apoptosis, focusing in particular on regulation of the survival pathway mediated by growth arrest-specific gene 6 (Gas6), a member of the vitamin K-dependent protein family, and its receptor, Axl. In human aortic smooth muscle cells (HASMC), statins significantly inhibited inorganic phosphate (Pi)-induced calcification in a concentration-dependent manner (reduced by 49% at 0.1 micromol/L atorvastatin). The inhibitory effect of statins was mediated by preventing apoptosis, which was increased by Pi in a concentration-dependent manner, and not by inhibiting sodium-dependent phosphate cotransporter (NPC) activity, another mechanism regulating HASMC calcification. Furthermore, the antiapoptotic effect of statins was dependent on restoration of Gas6, whose expression was downregulated by Pi. Restoration of Gas6 mRNA by statins was mediated by mRNA stabilization, and not by an increase in transcriptional activity. Suppression of Gas6 using small interfering RNA and the Axl-extracellular domain abolished the preventive effect of statins on Pi-induced apoptosis and calcification. These data demonstrate that statins protected HASMC from Pi-induced calcification by inhibiting apoptosis via restoration of the Gas6-Axl pathway.
Related Concept Videos
Atherosclerosis I: Introduction
The JAK-STAT Signaling Pathway
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...

